US20210244078A1 - Unexpectedly enhanced pigments compositions and processes - Google Patents
Unexpectedly enhanced pigments compositions and processes Download PDFInfo
- Publication number
- US20210244078A1 US20210244078A1 US17/241,046 US202117241046A US2021244078A1 US 20210244078 A1 US20210244078 A1 US 20210244078A1 US 202117241046 A US202117241046 A US 202117241046A US 2021244078 A1 US2021244078 A1 US 2021244078A1
- Authority
- US
- United States
- Prior art keywords
- flavor
- color
- odor
- alpha
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 146
- 239000000049 pigment Substances 0.000 title abstract description 22
- 238000000034 method Methods 0.000 title description 22
- 230000008569 process Effects 0.000 title description 3
- 239000000796 flavoring agent Substances 0.000 claims abstract description 101
- 235000019634 flavors Nutrition 0.000 claims abstract description 96
- 239000003205 fragrance Substances 0.000 claims abstract description 38
- 238000009472 formulation Methods 0.000 claims description 71
- 239000003557 cannabinoid Substances 0.000 claims description 35
- 229930003827 cannabinoid Natural products 0.000 claims description 35
- 150000003505 terpenes Chemical class 0.000 claims description 32
- 235000007586 terpenes Nutrition 0.000 claims description 32
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 claims description 30
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 claims description 28
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims description 28
- 229940065144 cannabinoids Drugs 0.000 claims description 28
- NVEQFIOZRFFVFW-RGCMKSIDSA-N caryophyllene oxide Chemical compound C=C1CC[C@H]2O[C@]2(C)CC[C@H]2C(C)(C)C[C@@H]21 NVEQFIOZRFFVFW-RGCMKSIDSA-N 0.000 claims description 28
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 28
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 claims description 28
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 claims description 28
- 230000008447 perception Effects 0.000 claims description 25
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 22
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 claims description 15
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 claims description 14
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 claims description 14
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 14
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 claims description 14
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 14
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 14
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 claims description 14
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 claims description 14
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 claims description 14
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 14
- PSVBPLKYDMHILE-UHFFFAOYSA-N alpha-humulene Natural products CC1=C/CC(C)(C)C=CCC=CCC1 PSVBPLKYDMHILE-UHFFFAOYSA-N 0.000 claims description 14
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 claims description 14
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 claims description 14
- 229930006722 beta-pinene Natural products 0.000 claims description 14
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 claims description 14
- RSYBQKUNBFFNDO-UHFFFAOYSA-N caryophyllene oxide Natural products CC1(C)CC2C(=C)CCC3OC3(C)CCC12C RSYBQKUNBFFNDO-UHFFFAOYSA-N 0.000 claims description 14
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 claims description 14
- 229930007744 linalool Natural products 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 208000035239 Synesthesia Diseases 0.000 claims description 10
- 235000001510 limonene Nutrition 0.000 claims description 10
- 229940087305 limonene Drugs 0.000 claims description 10
- 239000000443 aerosol Substances 0.000 claims description 7
- 240000006365 Vitis vinifera Species 0.000 abstract description 16
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract description 14
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract description 14
- 235000014787 Vitis vinifera Nutrition 0.000 abstract description 14
- 235000008733 Citrus aurantifolia Nutrition 0.000 abstract description 3
- 235000011941 Tilia x europaea Nutrition 0.000 abstract description 3
- 230000000763 evoking effect Effects 0.000 abstract description 3
- 239000004571 lime Substances 0.000 abstract description 3
- 235000011430 Malus pumila Nutrition 0.000 abstract 1
- 235000015103 Malus silvestris Nutrition 0.000 abstract 1
- 235000019658 bitter taste Nutrition 0.000 abstract 1
- 235000019645 odor Nutrition 0.000 description 52
- 238000012360 testing method Methods 0.000 description 27
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 24
- 238000004040 coloring Methods 0.000 description 24
- 241000218236 Cannabis Species 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 17
- 239000000126 substance Substances 0.000 description 15
- 239000003571 electronic cigarette Substances 0.000 description 14
- 229960002350 guaiazulen Drugs 0.000 description 13
- 235000013399 edible fruits Nutrition 0.000 description 12
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 11
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 11
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 11
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 11
- 239000003086 colorant Substances 0.000 description 10
- 244000078534 Vaccinium myrtillus Species 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 8
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 8
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 8
- 235000021014 blueberries Nutrition 0.000 description 8
- 235000016623 Fragaria vesca Nutrition 0.000 description 7
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 7
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- RCRCTBLIHCHWDZ-UHFFFAOYSA-N 2-Arachidonoyl Glycerol Chemical compound CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(CO)CO RCRCTBLIHCHWDZ-UHFFFAOYSA-N 0.000 description 6
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 6
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 6
- 229950011318 cannabidiol Drugs 0.000 description 6
- 235000020971 citrus fruits Nutrition 0.000 description 6
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 6
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 6
- 230000035943 smell Effects 0.000 description 6
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 6
- 235000009434 Actinidia chinensis Nutrition 0.000 description 5
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 5
- 241000207199 Citrus Species 0.000 description 5
- 235000005979 Citrus limon Nutrition 0.000 description 5
- 244000131522 Citrus pyriformis Species 0.000 description 5
- 241000675108 Citrus tangerina Species 0.000 description 5
- 240000009088 Fragaria x ananassa Species 0.000 description 5
- 235000010208 anthocyanin Nutrition 0.000 description 5
- 239000004410 anthocyanin Substances 0.000 description 5
- 229930002877 anthocyanin Natural products 0.000 description 5
- 150000004636 anthocyanins Chemical class 0.000 description 5
- -1 as well as colorings Substances 0.000 description 5
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 5
- 229960004242 dronabinol Drugs 0.000 description 5
- 235000012680 lutein Nutrition 0.000 description 5
- 239000001656 lutein Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical compound CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 244000307700 Fragaria vesca Species 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 4
- PMRJYBALQVLLSJ-UHFFFAOYSA-N chamazulene Natural products CCC1=CC2=C(C)CCC2=CC=C1 PMRJYBALQVLLSJ-UHFFFAOYSA-N 0.000 description 4
- 229960005375 lutein Drugs 0.000 description 4
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 4
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000779 smoke Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 4
- 102000018208 Cannabinoid Receptor Human genes 0.000 description 3
- 108050007331 Cannabinoid receptor Proteins 0.000 description 3
- 244000007645 Citrus mitis Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004216 Rhodoxanthin Substances 0.000 description 3
- VWXMLZQUDPCJPL-JCFHCUBBSA-N all-trans-Rhodoxanthin Natural products CC(=C/C=C/C(=C/C=C/1C(=CC(=O)CC1(C)C)C)/C)C=CC=CC(=CC=CC(=CC=C2/C(=CC(=O)CC2(C)C)C)C)C VWXMLZQUDPCJPL-JCFHCUBBSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000019568 aromas Nutrition 0.000 description 3
- 239000001055 blue pigment Substances 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 235000012754 curcumin Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000008369 fruit flavor Substances 0.000 description 3
- 239000001056 green pigment Substances 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 239000001053 orange pigment Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 235000019246 rhodoxanthin Nutrition 0.000 description 3
- 239000001052 yellow pigment Substances 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- DMASLKHVQRHNES-GMKWGACXSA-N (1s)-3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol Chemical compound C([C@@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-GMKWGACXSA-N 0.000 description 2
- ABTRFGSPYXCGMR-KXQOOQHDSA-N (3R)-beta,psi-caroten-3-ol Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C ABTRFGSPYXCGMR-KXQOOQHDSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 2
- AAXZFUQLLRMVOG-UHFFFAOYSA-N 2-methyl-2-(4-methylpent-3-enyl)-7-propylchromen-5-ol Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCC)=CC(O)=C21 AAXZFUQLLRMVOG-UHFFFAOYSA-N 0.000 description 2
- BBNYCLAREVXOSG-UHFFFAOYSA-N 2-palmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CO)CO BBNYCLAREVXOSG-UHFFFAOYSA-N 0.000 description 2
- 244000298697 Actinidia deliciosa Species 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004217 Citranaxanthin Substances 0.000 description 2
- XXGMIHXASFDFSM-UHFFFAOYSA-N Delta9-tetrahydrocannabinol Natural products CCCCCc1cc2OC(C)(C)C3CCC(=CC3c2c(O)c1O)C XXGMIHXASFDFSM-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 241000271567 Struthioniformes Species 0.000 description 2
- 239000004213 Violaxanthin Substances 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 235000012665 annatto Nutrition 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- 150000001545 azulenes Chemical class 0.000 description 2
- 235000012677 beetroot red Nutrition 0.000 description 2
- 239000001654 beetroot red Substances 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 235000012682 canthaxanthin Nutrition 0.000 description 2
- 239000001659 canthaxanthin Substances 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- BQOFWKZOCNGFEC-UHFFFAOYSA-N carene Chemical compound C1C(C)=CCC2C(C)(C)C12 BQOFWKZOCNGFEC-UHFFFAOYSA-N 0.000 description 2
- IRAQOCYXUMOFCW-OSFYFWSMSA-N cedr-8-ene Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1C(C)=CC2 IRAQOCYXUMOFCW-OSFYFWSMSA-N 0.000 description 2
- 235000019247 citranaxanthin Nutrition 0.000 description 2
- PRDJTOVRIHGKNU-UHFFFAOYSA-N citranaxanthine Natural products CC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-UHFFFAOYSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 235000012656 ethyl ester of beta-apo-8'-carotenic acid Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000007968 orange flavor Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 235000009514 rubixanthin Nutrition 0.000 description 2
- 239000000455 rubixanthin Substances 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000021012 strawberries Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 235000019245 violaxanthin Nutrition 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000010930 zeaxanthin Nutrition 0.000 description 2
- 239000001775 zeaxanthin Substances 0.000 description 2
- 229940043269 zeaxanthin Drugs 0.000 description 2
- YHAJBLWYOIUHHM-UHFFFAOYSA-N α-bulnesene Chemical compound C1CC(C(C)=C)CC2C(C)CCC2=C1C YHAJBLWYOIUHHM-UHFFFAOYSA-N 0.000 description 2
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- QEBNYNLSCGVZOH-NFAWXSAZSA-N (+)-valencene Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CCC=C21 QEBNYNLSCGVZOH-NFAWXSAZSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- GXEGJTGWYVZSNR-UHFFFAOYSA-N (1E,4Z)-germacrene B Chemical compound CC(C)=C1CCC(C)=CCCC(C)=CC1 GXEGJTGWYVZSNR-UHFFFAOYSA-N 0.000 description 1
- ZIUSSTSXXLLKKK-KOBPDPAPSA-N (1e,4z,6e)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 ZIUSSTSXXLLKKK-KOBPDPAPSA-N 0.000 description 1
- YYWZKGZIIKPPJZ-WEDXCCLWSA-N (1r,4s,5s)-4,6,6-trimethylbicyclo[3.1.1]heptan-4-ol Chemical compound C1[C@@]2([H])C(C)(C)[C@]1([H])CC[C@@]2(O)C YYWZKGZIIKPPJZ-WEDXCCLWSA-N 0.000 description 1
- STRABSCAWZINIF-FGRDXJNISA-N (1s,4as)-1,4a-dimethyl-7-propan-2-ylidene-3,4,5,6,8,8a-hexahydro-2h-naphthalen-1-ol Chemical compound C1CC[C@](C)(O)C2CC(=C(C)C)CC[C@@]21C STRABSCAWZINIF-FGRDXJNISA-N 0.000 description 1
- KXSDPILWMGFJMM-AEJSXWLSSA-N (1s,4r,5r)-4-methyl-1-propan-2-ylbicyclo[3.1.0]hexan-4-ol Chemical compound C([C@]1(O)C)C[C@]2(C(C)C)[C@H]1C2 KXSDPILWMGFJMM-AEJSXWLSSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- 239000001890 (2R)-8,8,8a-trimethyl-2-prop-1-en-2-yl-1,2,3,4,6,7-hexahydronaphthalene Substances 0.000 description 1
- CXENHBSYCFFKJS-UHFFFAOYSA-N (3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene Natural products CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 description 1
- WNRBYZQFEBIUGD-LSDHHAIUSA-N (4ar,8ar)-5,8a-dimethyl-3-propan-2-ylidene-1,2,4,4a,7,8-hexahydronaphthalene Chemical compound C1CC=C(C)[C@@H]2CC(=C(C)C)CC[C@]21C WNRBYZQFEBIUGD-LSDHHAIUSA-N 0.000 description 1
- ZROLHBHDLIHEMS-HUUCEWRRSA-N (6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCC)=CC(O)=C3[C@@H]21 ZROLHBHDLIHEMS-HUUCEWRRSA-N 0.000 description 1
- WUIFRGYQELQKDN-NTMALXAHSA-N (E)-Ocimene Natural products CC(C)CC\C=C(\C)C=C WUIFRGYQELQKDN-NTMALXAHSA-N 0.000 description 1
- IHPKGUQCSIINRJ-CSKARUKUSA-N (E)-beta-ocimene Chemical compound CC(C)=CC\C=C(/C)C=C IHPKGUQCSIINRJ-CSKARUKUSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- TYDDWHVJHGIJCW-OLKPEBQYSA-N (Z)-Ocimene Natural products O[C@@H](C(=C)C)C/C=C(/C=C)\C TYDDWHVJHGIJCW-OLKPEBQYSA-N 0.000 description 1
- IHPKGUQCSIINRJ-NTMALXAHSA-N (Z)-beta-ocimene Chemical compound CC(C)=CC\C=C(\C)C=C IHPKGUQCSIINRJ-NTMALXAHSA-N 0.000 description 1
- KAOXMQZGJURCQP-UHFFFAOYSA-M 1-[2-(2,3-dihydro-1,4-benzodioxin-5-yloxy)ethyl]-1-methylazepan-1-ium;iodide Chemical compound [I-].C=1C=CC=2OCCOC=2C=1OCC[N+]1(C)CCCCCC1 KAOXMQZGJURCQP-UHFFFAOYSA-M 0.000 description 1
- IEPGNWMPIFDNSD-HZJYTTRNSA-N 2-linoleoylglycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(CO)CO IEPGNWMPIFDNSD-HZJYTTRNSA-N 0.000 description 1
- WNRBYZQFEBIUGD-UHFFFAOYSA-N 3,7(11)-Eudesmadiene Natural products C1CC=C(C)C2CC(=C(C)C)CCC21C WNRBYZQFEBIUGD-UHFFFAOYSA-N 0.000 description 1
- UEUIKXVPXLWUDU-UHFFFAOYSA-N 4-diazoniobenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=C([N+]#N)C=C1 UEUIKXVPXLWUDU-UHFFFAOYSA-N 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 description 1
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 description 1
- 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 description 1
- 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 description 1
- UVOLYTDXHDXWJU-UHFFFAOYSA-N Cannabichromene Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-UHFFFAOYSA-N 0.000 description 1
- UVOLYTDXHDXWJU-NRFANRHFSA-N Cannabichromene Natural products C1=C[C@](C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-NRFANRHFSA-N 0.000 description 1
- REOZWEGFPHTFEI-JKSUJKDBSA-N Cannabidivarin Chemical compound OC1=CC(CCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-JKSUJKDBSA-N 0.000 description 1
- VBGLYOIFKLUMQG-UHFFFAOYSA-N Cannabinol Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCCCC)C=C3OC(C)(C)C2=C1 VBGLYOIFKLUMQG-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- SLQHGWZKKZPZEK-JKEZLOPUSA-N Citranaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)C)C=CC=C(/C)C=CC1=C(C)CCCC1(C)C SLQHGWZKKZPZEK-JKEZLOPUSA-N 0.000 description 1
- 241001471082 Colocasia bobone disease-associated cytorhabdovirus Species 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 description 1
- 240000002495 Cucumis melo var. inodorus Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- ZROLHBHDLIHEMS-UHFFFAOYSA-N Delta9 tetrahydrocannabivarin Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCC)=CC(O)=C3C21 ZROLHBHDLIHEMS-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- XURCUMFVQKJMJP-UHFFFAOYSA-N Dihydro-alpha-guaien Natural products C1C(C(C)C)CCC(C)C2=C1C(C)CC2 XURCUMFVQKJMJP-UHFFFAOYSA-N 0.000 description 1
- YJHVMPKSUPGGPZ-UHFFFAOYSA-N Dihydro-beta-eudesmol Natural products C1CC(C(C)(C)O)CC2C(C)CCCC21C YJHVMPKSUPGGPZ-UHFFFAOYSA-N 0.000 description 1
- ORKZJYDOERTGKY-UHFFFAOYSA-N Dihydrocannabichromen Natural products C1CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 ORKZJYDOERTGKY-UHFFFAOYSA-N 0.000 description 1
- PVNVIBOWBAPFOE-UHFFFAOYSA-N Dinoxanthin Natural products CC1(O)CC(OC(=O)C)CC(C)(C)C1=C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1(C(CC(O)C2)(C)C)C2(C)O1 PVNVIBOWBAPFOE-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000207620 Euterpe oleracea Species 0.000 description 1
- 235000012601 Euterpe oleracea Nutrition 0.000 description 1
- 239000004211 Flavoxanthin Substances 0.000 description 1
- JRHJXXLCNATYLS-NGZWBNMCSA-N Flavoxanthin Chemical compound C/C([C@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-NGZWBNMCSA-N 0.000 description 1
- QHUMOJKEVAPSCY-JOJDNVQPSA-N Flavoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1(C)OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C QHUMOJKEVAPSCY-JOJDNVQPSA-N 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- MCNAURNYDFSEML-UHFFFAOYSA-N Guaiane Natural products CC1CCC(C(C)=C)C(O)C2=C(C)C(=O)CC12 MCNAURNYDFSEML-UHFFFAOYSA-N 0.000 description 1
- TWVJWDMOZJXUID-SDDRHHMPSA-N Guaiol Chemical compound C1([C@H](CC[C@H](C2)C(C)(C)O)C)=C2[C@@H](C)CC1 TWVJWDMOZJXUID-SDDRHHMPSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- XMRKUJJDDKYUHV-UHFFFAOYSA-N Helminthogermacrene Natural products CC(=C)C1CCC(C)=CCCC(C)=CC1 XMRKUJJDDKYUHV-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- OTGQIQQTPXJQRG-UHFFFAOYSA-N N-(octadecanoyl)ethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCO OTGQIQQTPXJQRG-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- VWXMLZQUDPCJPL-ZDHAIZATSA-N Rhodoxanthin Chemical compound CC\1=CC(=O)CC(C)(C)C/1=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C1\C(C)=CC(=O)CC1(C)C VWXMLZQUDPCJPL-ZDHAIZATSA-N 0.000 description 1
- VWXMLZQUDPCJPL-XPZLFLLQSA-N Rhodoxanthin Natural products O=C1C=C(C)/C(=C\C=C(/C=C/C=C(\C=C\C=C\C(=C/C=C/C(=C\C=C\2/C(C)=CC(=O)CC/2(C)C)/C)\C)/C)\C)/C(C)(C)C1 VWXMLZQUDPCJPL-XPZLFLLQSA-N 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- PGALBDQPIPNYGS-CABCVRRESA-N Selina-3,7(11)-diene Natural products C(\C)(/C)=C\1/C[C@@]2(C)C(C)=CCC[C@@H]2CC/1 PGALBDQPIPNYGS-CABCVRRESA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 101150013568 US16 gene Proteins 0.000 description 1
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 235000019666 ageusia Nutrition 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- PGYAYSRVSAJXTE-CLONMANBSA-N all-trans-neoxanthin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C=C=C1C(C)(C)C[C@H](O)C[C@@]1(C)O PGYAYSRVSAJXTE-CLONMANBSA-N 0.000 description 1
- ADIDQIZBYUABQK-UHFFFAOYSA-N alpha-Guaiene Natural products C1C(C(C)=C)CCC(C)C2=C1C(C)CC2 ADIDQIZBYUABQK-UHFFFAOYSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- IPZIYGAXCZTOMH-UHFFFAOYSA-N alpha-eudesmol Natural products CC1=CCCC2CCC(CC12)C(C)(C)O IPZIYGAXCZTOMH-UHFFFAOYSA-N 0.000 description 1
- ADIDQIZBYUABQK-RWMBFGLXSA-N alpha-guaiene Chemical compound C1([C@H](CC[C@H](C2)C(C)=C)C)=C2[C@@H](C)CC1 ADIDQIZBYUABQK-RWMBFGLXSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000001670 anatto Substances 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- DFMMVLFMMAQXHZ-CMGSAFQJSA-N apocarotenal Chemical compound O=CC(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C=CC1=C(C)CCCC1(C)C DFMMVLFMMAQXHZ-CMGSAFQJSA-N 0.000 description 1
- 229940019834 apocarotenal Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QFFVPLLCYGOFPU-UHFFFAOYSA-N barium chromate Chemical compound [Ba+2].[O-][Cr]([O-])(=O)=O QFFVPLLCYGOFPU-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- XFSVWZZZIUIYHP-UHFFFAOYSA-N beta-Eudesmol Natural products CC(C)(O)C1CCC2CCCC(=C)C2C1 XFSVWZZZIUIYHP-UHFFFAOYSA-N 0.000 description 1
- 239000001652 beta-apo-8'-carotenal Substances 0.000 description 1
- 235000013735 beta-apo-8'-carotenal Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- BOPIMTNSYWYZOC-VNHYZAJKSA-N beta-eudesmol Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(C)(O)C)CC[C@]21C BOPIMTNSYWYZOC-VNHYZAJKSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- REOZWEGFPHTFEI-UHFFFAOYSA-N cannabidivarine Natural products OC1=CC(CCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-UHFFFAOYSA-N 0.000 description 1
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 238000003965 capillary gas chromatography Methods 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- PRDJTOVRIHGKNU-ZWERVMMHSA-N citranaxanthin Chemical compound CC(=O)\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-ZWERVMMHSA-N 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 description 1
- 235000012700 copper complexes of chlorophylls and chlorophyllins Nutrition 0.000 description 1
- HWDGVJUIHRPKFR-ZWPRWVNUSA-I copper;trisodium;3-[(2s,3s)-20-(carboxylatomethyl)-18-(dioxidomethylidene)-8-ethenyl-13-ethyl-3,7,12,17-tetramethyl-2,3-dihydroporphyrin-23-id-2-yl]propanoate Chemical compound [Na+].[Na+].[Na+].[Cu+2].C1=C([N-]2)C(CC)=C(C)C2=CC(C(=C2C)C=C)=NC2=CC([C@H]([C@@H]2CCC([O-])=O)C)=NC2=C(CC([O-])=O)C2=NC1=C(C)C2=C([O-])[O-] HWDGVJUIHRPKFR-ZWPRWVNUSA-I 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- HCAWPGARWVBULJ-IAGOWNOFSA-N delta8-THC Chemical compound C1C(C)=CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 HCAWPGARWVBULJ-IAGOWNOFSA-N 0.000 description 1
- IRAQOCYXUMOFCW-UHFFFAOYSA-N di-epi-alpha-cedrene Natural products C1C23C(C)CCC3C(C)(C)C1C(C)=CC2 IRAQOCYXUMOFCW-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000006274 endogenous ligand Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 239000001684 ethyl ester of beta-apo-8'-carotenic acid (C30) Substances 0.000 description 1
- 229930009668 farnesene Natural products 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 235000019243 flavoxanthin Nutrition 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- GIRXTOSJOKKBHO-BQTUIHPCSA-N food orange 7 Chemical compound CCOC(=O)C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C GIRXTOSJOKKBHO-BQTUIHPCSA-N 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- GXEGJTGWYVZSNR-OMQMMEOVSA-N germacrene-B Natural products CC(C)=C1CC\C(C)=C/CC\C(C)=C/C1 GXEGJTGWYVZSNR-OMQMMEOVSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- QAQCPAHQVOKALN-RMEBNNNOSA-N guaiane Chemical class C1[C@H](C(C)C)CC[C@H](C)[C@@H]2CC[C@H](C)[C@@H]21 QAQCPAHQVOKALN-RMEBNNNOSA-N 0.000 description 1
- TWVJWDMOZJXUID-QJPTWQEYSA-N guaiol Natural products OC(C)(C)[C@H]1CC=2[C@H](C)CCC=2[C@@H](C)CC1 TWVJWDMOZJXUID-QJPTWQEYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- IEPGNWMPIFDNSD-UHFFFAOYSA-N linoleic acid monoacylglycerol Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC(CO)CO IEPGNWMPIFDNSD-UHFFFAOYSA-N 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- OWAAYLVMANNJOG-OAKWGMHJSA-N neoxanthin Natural products CC(=C/C=C(C)/C=C/C=C(C)/C=C=C1C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC23OC2(C)CC(O)CC3(C)C OWAAYLVMANNJOG-OAKWGMHJSA-N 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 238000013027 odor testing Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- ABTRFGSPYXCGMR-SDPRXREBSA-N rubixanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)/C)=C(C)C1 ABTRFGSPYXCGMR-SDPRXREBSA-N 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- KXSDPILWMGFJMM-UHFFFAOYSA-N trans-sabinene hydrate Natural products CC1(O)CCC2(C(C)C)C1C2 KXSDPILWMGFJMM-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- WCTNXGFHEZQHDR-UHFFFAOYSA-N valencene Natural products C1CC(C)(C)C2(C)CC(C(=C)C)CCC2=C1 WCTNXGFHEZQHDR-UHFFFAOYSA-N 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 229930000038 α-guaiene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
- A24B15/303—Plant extracts other than tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
- A24B15/345—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring containing condensed rings
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/50—Control or monitoring
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/10—Devices using liquid inhalable precursors
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
Definitions
- the color of a food and colorings added to a food are visual cues on taste and flavor. Greater color intensity can influence a subject's rating of a substance as having a greater intensity flavor and can also influence identification of the flavor. Color can also tip the balance between two different perceptions of odor or flavor, for example, the perceptions of sweet versus sour. Odors can modify behavior, generate emotions, and evoke memories. Color can influence odor perception as shown, for example, by aroma determination tests of wine. See, e.g., Morrot, G. et al. (2001) Brain and Language. 79:309-320. Regarding odor itself, odor testing can result in experimental data taking the form of reports of pleasantness, unpleasantness, intensity, and duration of memory of a given odor.
- An example is oenophiles given white wine that has been colored red who described it with red wine flavor descriptors.
- a cause of decreased food intake that occurs with advancing age is loss of taste and smell acuity.
- the present disclosure provides compositions for use in flavor-amplified foods to improve nutritional status in elderly persons.
- the present disclosure provides cannabis compositions, optionally with flavorings and colorings, to improve appetite.
- compositions and formulations where a coloring is included, and where the particular color influenced the subject towards certain odor-perceptions and also influenced the same subject away from other odor-perceptions.
- the present disclosure provides a formulation comprising a coloring and an odorant, wherein the odorant provides a perceivable odor to the formulation, and wherein the coloring provides a perceivable color to the formulation. Also provided, is the above formulation, wherein in the coloring in pure form does not have a perceivable odor, and wherein the odorant in purified form does not have a perceivable color.
- the formulation comprises an odorant, wherein the odorant in purified form has a first odor, wherein the odorant in purified form mixed with a coloring in purified form has a second odor, and wherein the first odor is more intense than the second odor as determinable with perception tests with human subjects.
- the formulation comprises an odorant, wherein the odorant in purified form has an odor, wherein the odorant in purified form mixed with a coloring in purified form has the same odor, but wherein, the odorant mixed with a coloring is more recognizable and/or more enjoyable as determined via perception tests with human subjects.
- the formulation can be used in an electronic cigarette.
- the electronic cigarette emits a smoke, wherein the coloring is perceived as having a color in the smoke emitted by the electronic cigarette or the coloring is not perceived at coloring the smoke at all.
- the formulation can be used in a beverage for human consumption. In yet another embodiment described herein, the formulation can be used in one or more of a skin lotion, perfume, and/or cosmetic. In yet another embodiment described herein, the formulation can be used in a confection, cake frosting, and/or candy. In one aspect of an embodiment described herein, the formulation comprises at least one plant pigment and at least one cannabinoid. In another aspect of an embodiment described herein, the formulation comprises at least one plant pigment and at least one terpene. In yet another aspect of an embodiment described herein, the formulation comprises at least one non-plant pigment and at least one cannabinoid. In yet another aspect of an embodiment described herein, the formulation comprises at least one non-plant pigment and at least one terpene.
- the formulation comprises D-Limonene, beta-caryophyllene, beta-myrcene, linalool, beta-pinene, alpha-humulene, alpha-bisabolol, alpha-pinene, and terpinolene; optionally with orange pigment (Tangie).
- the formulation does not comprise any caryophyllene-oxide.
- the formulation comprises an orange pigment, wherein the orange pigment acts by synesthesia to increase preference by a human subject of one or both of the odor or flavor of Tangie.
- the formulation comprises D-Limonene, beta-pinene, beta-caryophyllene, beta-myrcene, linalool, alpha-humulene, alpha-bisabolol, alpha-pinene, and terpinolene; optionally with yellow pigment (Lemon Kush).
- the formulation does not comprise any caryophyllene-oxide.
- the formulation comprises a yellow pigment, wherein the yellow pigment acts by synesthesia to increase preference by a human subject of one or both of the odor or flavor of Lemon Kush.
- the formulation comprises D-Limonene, beta-myrcene, alpha-pinene, beta-caryophyllene, beta-pinene, alpha-humulene, linalool, alpha-bisabolol, caryophyllene-oxide, and terpinolene; optionally with green pigment (Lime Dream).
- the formulation comprises a green pigment, wherein the green pigment acts by synesthesia to increase preference by a human subject of one or both of the odor or flavor of Lime Dream.
- the formulation comprises beta-myrcene, beta-caryophyllene, D-Limonene, alpha-pinene, alpha-humulene, beta-pinene, linalool, alpha-bisabolol, terpinolene, caryophyllene-oxide, and terpinolene; optionally with blue pigment (Berry Cush).
- the formulation comprises a blue pigment, wherein the blue pigment acts by synesthesia to increase preference by a human subject of one or both of the odor or flavor of Berry Cush.
- odorant and flavorant formulations that are representative of the specific fruit moniker used in the odorant and flavorant name (e.g. Lime Dream). These examples are not intended to restrict the general principle of pairing a flavorant or odorant formulation that is representative of a fruit that is associated with a dominant color.
- the present disclosure also provides a formulation for use in an electronic cigarette, wherein the formulation comprises 0.05%-5% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids, and wherein the perception of grape odor is greater than that for a formulation comprising 0-0.03% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids.
- the present disclosure also provides a formulation comprising about 10% terpenes, about 65% phytol, about 24.5% cannabinoids, and guaiazulene in an amount selected from the group consisting of 0%, 0.01%, 0.02%, 0.05%, 0.1%, 0.5%, 2.0%, 5.0%, and 10% guaiazulene.
- the present disclosure provides a formulation for use in an electronic cigarette, wherein the formulation comprises 0.05%-5% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids, and wherein the perception of grape odor is greater than that for a formulation comprising 0%-0.03% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids.
- the present disclosure provides a formulation for use in an electronic cigarette, wherein the formulation comprises 0.01%-0.05% chamazulene, about 5% terpenes, and about 94.99% cannabinoids, and wherein the perception of grape odor is greater than that for a formulation comprising 0%-0.005% chamazulene, about 5% terpenes, and about 94.99% cannabinoids.
- coloring refers to a physical entity such as a chemical, molecule, metal ion, complex of metal ion. light-producing element, like a light-emitting diode (LED), and a molecule, composition comprising one or more of the above, composition consisting of one or more of the above, and the like, where the “coloring” is perceivable as having a color.
- a “coloring” in a relatively pure form or in a pure form is perceivable as having a color
- the “coloring” is perceivable as having a color only when subject to a specific environmental condition, such as an acid pH or a neutral pH.
- the color can be selected from the group consisting of violet, indigo, blue, green, yellow, orange, red, and a combination thereof.
- odorant refers to a chemical compound or a mixture of chemical compounds with a smell detectable by a human nose.
- flavorant refers to a flavor additive or multiple flavor additives that modify the flavor of a composition compared to if the flavorant was not present.
- pigment refers to a composition or compositions that can be identified or distinguished by names of chemicals and where the pigment is perceivable as having a color.
- colorant refers to a substance or a mixture of substances that is added to change the color of a composition.
- the formulation may comprise one or more terpenes selected from the group consisting of alpha-bisabolol, borneol, camphene, camphor, beta-caryophyllene, delta-3-carene, caryophyllene oxide, alpha-cedrene, beta-eudesmol, fencholfenchyl alcohol, geraniol, guaiol, alpha-humulene, isoborneol, limonene, linalool, menthol, myrcene, nerol, nerolidol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, sabinene, 4-thujanol, alpha-terpinene, alpha-terpineol, terpinolene, alpha-guaiene, elemene, farnesene, farne
- the formulation may comprise one or more cannabinoids selected from the group consisting of tetrahydrocannabinol, delta-9-tetrahydrocannabinol (THC), delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol propyl analogue (THCV), cannabidiol (CBD), cannabidiol propyl analogs (CBDV), cannabinol (CBN), cannabichromene (CBC), cannabichromene propyl analogs (CBCV), cannabigerol (CBG), their corresponding cannabinoid acid counterparts, and a mixture thereof.
- cannabinoids selected from the group consisting of tetrahydrocannabinol, delta-9-tetrahydrocannabinol (THC), delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol propyl analogue (THCV), can
- a formulation described herein may comprise carriers or diluting oils such as dipropylene glycol, coconut oil, and glucam P-20, propylene glycol, triacetin, vegetable glycerin are available from, e.g., Perfumers Apprentice (Scotts Valley, Calif.). Colorings and pigments are available from, e.g., American Colors, Inc., Sandusky, Ohio. Natural aroma chemicals, synthetic aroma chemicals, and essential oils and extracts are available from, for example, Vigon International, East Stroudsburg, Pa.. Violet-colored azulene compounds are disclosed by, e.g., Hayashi (1968) Bulletin of the Chemical Society of Japan. 41:2182-2183.
- Standard color charts are available, for example, from Long, J. (2011) The New Munsell Student Color Set, 3rd ed. Fairchild Books; Centore, P. (2015) Controlling Colour With the Munsell System. ISBN-10:1632270129.
- the Munsell System is used in psychology experiments. See, e.g., Gilbert, A. N. et al. (1006) Cross-modal correspondence between vision and olfaction: the color of smells. Am. J. Psychology. 109:335-351.
- RAL color charts are available from Color Harzen. General chemical reagents, as well as colorings, solvents, and surfactants are available (Sigma Aldrich, St. Louis, Mo.; Fischer Chemicals, Fair Lawn, N.J.; Ceriliiant, Round Rock, Tex.; Promochem, Molsheim, France, Cayman Chemical Co., Ann Arbor, Mich.).
- Useful labels include 33P, 35S, 14C, 3H, stable isotopes, fluorescent dyes, or fluorettes. See, e.g., Rozinov and Nolan (1998) Chem. Biol. 5:713-728.
- Terpenes, cannabinoids, formulations, and methods for preparation and analysis are available from US2015/0080265 of Elzinga and Raber, US2015/0152018 of Raber and Elzinga, 2017/0021029 of Raber et al, and 2016/0151328 of Doane and Raber, the disclosures of each of which are incorporated herein in their entirety.
- compositions, reagents, and combinations of reagents that act by way of synesthesia.
- Synesthesia encompasses, but is not limited to, a phenomenon where a stimulus in one sensory mode is interpreted in terms of some other sensory mode.
- colors can bias odor judgments.
- Odor judgments include, and are not limited to, accuracy in odor identification.
- a synesthesia questionnaire can take the form of a paper that invokes a mood, such as angry, tired, proud, peaceful, surprised, excited, joyful, and so on, and where the subjected reports the evoked mood (e.g., yellow perceived as joyful, red as surprised, blue as peaceful). Also, the subject can be presented with an odor sample, and be asked to report the evoked color.
- Fragrances of the present disclosure can be dissolved in diethyl phthalate, where odor chemicals are present in an amount ranging from 0.1% to 80% of the amount of the composition.
- the odor chemical are present in an amount ranging from 0.1% to 1%, 0.5% to 2.0%, 1.0% to 5.0%, 2.5% to 7.5%, 5% to 10%, 7.5% to 15%, 10% to 20%, 15% to 25%, 20% to 30%, 25% to 35%, 30% to 40%, 35% to 45%, 40% to 50%, 45% to 55%, 50% to 60%, 55% to 65%, 60% to 70%, 65% to 75%, or 70% to 80% of the amount of the composition.
- the odor chemical can be used at 100% strength. See, Gilbert, A. N. et al. (1996) Am. J. Psychology. 109:335-351; and Rader and Tellegen (1987) J. Personality and Social Psychology. 52:981-987.
- compositions, formulations, solutions, and the like can be used with an electronic cigarette (e-cigarette).
- Apparatus and formulations for e-cigarettes are available. See, U .S. Pat. No. 9,254,002 of Chong and U.S. Pat. No. 8,997,753 of Li, which are incorporated herein in their entirety.
- the compositions, formulations, and solutions of the present disclosure can be converted to an aerosol, and in other embodiments, take the form of an aerosol.
- the reagents and compositions of the present disclosure can be used in combination with, or can be contained within, one or more of the devices described herein.
- the devices include a moist towel in a tearable aluminum foil envelope; scented soft paper tissue, e.g., Kleenex®.; a cartridge that goes inside a bong, or water pipe, or hookah, where the composition supplements the flavor or medicinal effects of the marijuana smoke; an inhaler for people with asthma, where the composition is mixed with and supplements the anti-inflammatory drugs present in the inhaler; coaled porous particles and/or coated non-porous particles, wherein the particles have terpenes and cannabinoids soaked into the particles; mixed in a hangover treatment (not necessary medicinal); as part of a composition with capsaicin (chili pepper chemical) for use in treating pain, for topical application, for arthritis pain or as part of an existing arthritis pain topical cream; lip balm; and/or as a component of an oil-based cosmetic for skin.
- Dabs are a means for consuming cannabis concentrates via vaporization and inhalation.
- a dab usually refers to a dose of concentrate that is heated on a hot surface, usually a nail, and then inhaled through a dab rig.
- Dabs are concentrated doses of cannabis that are made by extracting THC and other cannabinoids using a solvent such as butane or carbon dioxide, resulting in sticky oils commonly referred to as wax, shatter, budder, and/or butane hash oil (BHO). While it is possible to extract non-psychoactive compounds like CBD, THC is what is behind the potent effects of dabs, increasing efficiency in administration of medications. Terpenes or the aromatic oils that give cannabis flavor, can also be extracted.
- the present disclosure provides methods of use, methods of manufacture, and compositions and reagents for use with administration by way of dabs.
- ECIG COMPONENTS The present disclosure provides devices and methods for storing the compositions described herein inside of a vapor cartridge (ecig component) or other device or object.
- Devices and objects may be color coded to indicate flavor suggestions, and optionally also to indicate if it contains THC or CBD (or other cannabinoid).
- a non-limiting physical structure of the ecig includes: (1) chip/microcontroller for voltage regulation, run lights or vibration, flow cell monitoring; (2) LEDs/vibrating motor for visual and tactile feedback; (3) battery or other energy source to supply power; (4) a chamber to hold material to be vaporized, wherein the chamber can be of many shapes and materials; (5) mouthpiece; (6) heating element to vaporize the material, wherein the heating element can be made in many shapes and material; (7) 510 thread as a standardized linkage between cartridges of material and the battery/electronics.
- the chamber part also known as a cartridge
- Compositions could be placed in vapor cartridges that are transparent in their construction to allow seeing the composition.
- odorant perception tests are also described herein.
- test subjects are instructed to describe the odor of various fruit solutions, some of which are inappropriately colored. Then, subjects are presented with a series of fruit solutions which vary in odor and color intensity and then asked to rank them in order of odor strength. See, Blackwell L (1995) Nutrition and Food Science. 95:24-28.
- an odorant is presented in one of 16 different dilutions. The odorant may or may not be colored. Also, a picture or photograph of a possible source of the odorant may or may not be shown to the subject, for example, a picture of a ham, cookie, or melon. The subject then identifies the odorant.
- Entourage compounds and entourage effects are encompassed by the present disclosure.
- the methods, compositions, reagents, and devices of the present disclosure encompass entourage effects of cannabis and cannabinoids, including entourage effects provided by terpenes. Interactions between phytocannabinoids and terpenoid compounds can act synergistically for treating pain, inflammation, depression, anxiety, and addiction. Ben-Shabat, et al. provide an example of an entourage effect.
- 2-Arachidonoyl-glycerol is an endogenous ligand for both cannabinoid receptors, CB1 and CB2.
- the biological activity of 2-arachidonoyl-glycerol can be increased by related 2-acyl-glycerols, which alone show little or no activity.
- Ethanolamines such as palmitoylethanolamine or stearoylethanolamine do not bind to CB1 or CB2 cannabinoid receptors, but they potentiate activity of ligands of cannabinoid receptors. See, Huestis (2002) Forensic Sci. Rev. 14:15-60.
- the method of conducting odor and flavor testing described herein involves asking subjects to identify a specific odor or flavor presented to them and then to tally the number of correct answers versus incorrect answers.
- the human subjects can be asked to rate the enjoyment of the flavor and or aroma of a product.
- both of these tests can be done while exposing the subject to light from an LED that is emitting either a matched color (i.e. the dominant color associated with a fruit, e.g. lime with green) or a mismatched color (e.g. lime with red).
- a matched color i.e. the dominant color associated with a fruit, e.g. lime with green
- a mismatched color e.g. lime with red
- a method of conducting odor and flavor testing described herein, in specific terms, involves presenting a human subject with an unmarked e-cigarette containing a formulation consisting, by weight percentage, of 10% flavor/odorant formulation, 10% cannabidiol, and 80% phytol; wherein the composition of the flavorant/odorant blend varies as demonstrated in the examples that follow.
- an LED light ELlight brand 300 color LED controlled with the LED Hue iPhone app
- ELlight brand 300 color LED controlled with the LED Hue iPhone app is switched on to a specific color and maintained on that color until the subject verbally records flavor/aroma identification assessments and an overall enjoyment rating from 1-10 with 1 being the least enjoyment and 10 meaning the most enjoyment possible.
- Each subject is presented the same flavor twice—once with a matched color and once with a mismatched color. This allows for the measurement of the impact that the color from the LED has on the flavor identity assessments and overall enjoyment, in a relative way.
- Table 1 illustrates mapping of dominant colors (i.e. matched colors) used in the experimental protocol described in the preceding paragraphs to the wavelength ranges of light emitted by LED.
- Strawberry cough is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (27%) , beta-pinene (5%), beta-caryophyllene (17%), beta-myrcene (17%), linalool (6%), alpha-humulene (3%), alpha-bisabolol (2%), alpha-pinene (2%), terpinolene ( ⁇ 1%), and caryophyllene-oxide ( ⁇ 1%).
- This formula also comprises a compound found in strawberries, but not found in cannabis. As such, the taste and odor of the composition is both of strawberries and of the cannabis strain strawberry cough.
- Tangie is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (22%), beta-pinene (4%), beta-caryophyllene (17%), beta-myrcene (17%), linalool (7%), alpha-humulene (4%), alpha-bisabolol (2%), alpha-pinene (2%), terpinolene ( ⁇ 1%), and caryophyllene-oxide ( ⁇ 1%).
- This formula also comprises multiple compounds found in tangerines and other citrus fruit, but not found in cannabis. As such, the taste and odor of the composition is both of tangerines/citrus and of the cannabis strain Tangie.
- Lemon Kush is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (49%) , beta-pinene (9%), beta-caryophyllene (9%), beta-myrcene (9%), linalool (3%), alpha-humulene (2%), alpha-bisabolol (1%), alpha-pinene (1%), terpinolene ( ⁇ 1%), and caryophyllene-oxide ( ⁇ 1%).
- This formula also comprises multiple compounds found in lemons, but not found in cannabis. As such, the taste and odor of the composition is both of lemons and of the cannabis strain Lemon Kush.
- Kiwi Kush is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (12%) , beta-pinene (2%), beta-caryophyllene (19%), beta-myrcene (7%), linalool (3%), alpha-humulene ( ⁇ 1%), alpha-bisabolol (3%), alpha-pinene (1%), terpinolene ( ⁇ 1%), and caryophyllene-oxide ( ⁇ 1%).
- This formula also comprises multiple compounds found in kiwis, but not found in cannabis. As such, the taste and odor of the composition is both of kiwis and of cannabis.
- Blueberry Flame is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (25%) , beta-pinene (5%), beta-caryophyllene (16%), beta-myrcene (24%), linalool (5%), alpha-humulene (3%), alpha-bisabolol (1%), alpha-pinene (2%), terpinolene ( ⁇ 1%), and caryophyllene-oxide ( ⁇ 1%).
- This formula also comprises one compound found in blueberries, but not found in cannabis. As such, the taste and odor of the composition is both of blueberries and of cannabis.
- Grapeness is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (18%), beta-pinene (4%), beta-caryophyllene (13%), beta-myrcene (13%), linalool (5%), alpha-humulene (3%), alpha-bisabolol (2%), alpha-pinene (2%), terpinolene ( ⁇ 1%), and caryophyllene-oxide ( ⁇ 1%).
- This formula also comprises multiple compounds found in grapes, but not found in cannabis. As such, the taste and odor of the composition is both of grapes and of cannabis.
- the matched fruit flavors/aromas and dominant color light pairings highlighted in examples 1-6 resulted in an average of two more correct representative flavor assessments than incorrect.
- the mismatched flavors resulted in an average of two more incorrect flavor assessments than correct.
- the matched fruit flavors/aromas and dominant color light pairings resulted in an average enjoyment score of 6 out of 10 across all flavors while the mismatched fruit flavors/aromas and dominant color light pairings resulted in an average enjoyment score of 5 out of 10.
- the term pigment refers to compositions that can be identified or distinguished by names of chemicals and where the pigment is perceivable as having a color.
- the term color refers to what is perceived by a human subject. The color can also be determined by a spectrophotometer.
- Potential Pigments can be selected from the group consisting of Guaiene sesquiterpenes, carotenoids, anthocyanins, anthocyanidins, and diarylheptanoids.
- Guaiane sesquiterpenes guaiazulene and vetriazulene
- xanthophylls bixins E160b, apocarotenal E160e, food orange 7 E160f, flavoxanthin E161 a, lutein E161 b cryptoxanthin E161c, rubixanthin E161d.
- violaxanthin E161e violaxanthin E161e, rhodoxanthin E161f, canthaxanthin E161g, zeaxanthin E161f, citranaxanthin E161i, astaxanthin E161j).
- carotenes lycopene E160d, beta-carotene E160a
- diarylheptanoids curcumin E100, curcumenoids
- Antbocyanidins and anthocyanins betanin (E162), carmine, chlorophyllin (E141) natural green 3.
- Native Pigments can be selected from the group consisting of neoxanthin, violaxenthin, zeaxanthin, lutein, b-cryptoxanthin, b-carotene, chlorophyll a & b, and guaizulene.
- Guaiazulene can be used to color a clear extract shades of blue or yellow extract shades of yellow-green.
- Carotene and lutein can be used to color extracts orange.
- Lycopene can be used to color extracts orange-red.
- Curcumins can be used to color an extract bright yellow and make them fluoresce under UV radiation. Guaiazulene and curcumins together can make shades of green that fluoresce.
- Anthocyanins can make extracts many shades of purple, red and blue.
- Smell of Pigments The present disclosure demonstrates that the pigmentation of cannabis extracts does not lead to off flavors.
- Solubilities of Pigments are only soluble in dipropylene glycol (i.e. OBP), not in nexus or cannabinoids alone.
- OBP dipropylene glycol
- Anthocyanins in OBP can be added to cannabinoids and terpenes to make red colored extracts.
- Guaiazulene is soluble in cannabinoids, terpenes, nexus, and obp and all useful combinations.
- Curcumins are soluble at necessary levels for full pigmentation of obp, nexus, and terpenes. Lutein and carotene are soluble in obp, nexus, terpenes, and cannabinoids.
- Pigments may be modified by use of light, lightwaves, ultrasonic waves, other sound wave, and wave influences. LED lights on apparatuses that may contain the pigments or be in touch with the pigments, being soluble in obp, nexus, terpenes or cannabinoids.
- the present disclosure provides, without implying any limitation, protocol for testing preferences by human subjects.
- the protocol can require that human subject designate either preferred or not preferred.
- Another embodiment for protocol can require that the subject designate preference in terms of a scale, for example, a scale ranging from zero (least preferred) to ten (most preferred), where the scale takes the form of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.
- the scale can range from zero to two (0, 1, 2), or zero to three (0, 1, 2, 3), or zero to four (0, 1, 2, 3, 4), and the like.
- the process and composition of the present disclosure can exclude any composition, or can exclude any method that uses a composition, where the composition was not determined to be preferred by at least 50% of a population of human subjects (where preference was determined under controlled laboratory testing conditions).
- the composition can require preference by human subjects in a controlled laboratory testing environment, that a given composition be preferred (in tests given only the option of preferred versus not preferred), by at least 20%, by at least 30%, by at least 40%, by at least 50%, by at least 60%, by at least 70%, by at least 80%, by at least 90%, or by at least 95% of the human subjects.
- the composition can require preference by human subjects in a controlled laboratory testing environment, that a given composition be preferred (in tests giving the options of zero (least preferred), one, and two (most preferred)), that a preference value of “two” is designated by at least 20%, by at least 30%, by at least 40%, by at least 50%, by at least 60%, by at least 70%, by at least 80%, by at least 90%, or by at least 95% of the human subjects.
- the composition can require preference by human subjects in a controlled laboratory testing environment, that a given composition be preferred (in tests giving the options of zero (least preferred), one, two, and three (most preferred)), that a preference value of “two” is designated by at least 20%, by at least 30%, by at least 40%, by at least 50%, by at least 60%, by at least 70%, by at least 80%, by at least 90%, or by at least 95% of the human subjects.
- the composition can require preference by human subjects in a controlled laboratory testing environment, that a given composition be preferred (in tests giving the options of zero (least preferred), one, two, and three (most preferred)), that a preference value of “three” is designated by at least 20%, at least 30%, by at least 40%, by at least 50%, by at least 60%, by at least 70%, by at least 80%, by at least 90%, or by at least 95% of the human subjects.
- This criterion optionally can be combined with the criterion set forth in the previous paragraph.
- compositions or methods where the composition was not determined to be preferred by at least 60%, by at least 70%, by at least 80%, by at least 85%, by at least 90%, by at least 95%, by at least 99% of the human subjects.
- the term “preferred” can refer to tests that required either a yes/no preference level.
- compositions and method where at least 50% of the subjects did not designate at least a “two,” or where at least 50% of the subjects did not designate at least a “three,” or where at least 50% of the subjects did not designate at least a “four,” or where at least 50% of the subjects did not designate at least a “five,” or where at least 50% of the subjects did not designate at least a “six” or where at least 50% of the subjects did not designate at least a “seven,” or where at least 50% of the subjects did not designate at least an “eight,” and so on.
Abstract
Description
- This application is a continuation-in-part of U.S. patent application Ser. No. 16/007,936, filed Jun. 13, 2018, which claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 62/518,703, filed Jun. 13, 2017, the disclosures of all of which are incorporated by reference herein in their entirety.
- This disclosure relates to consumables such as electronic cigarettes, candles, incense, perfumes, beverages, and snack foods. The disclosure provides colorants and odorants, and formulations thereof, where the colorant influences the perceived odor.
- The color of a food and colorings added to a food are visual cues on taste and flavor. Greater color intensity can influence a subject's rating of a substance as having a greater intensity flavor and can also influence identification of the flavor. Color can also tip the balance between two different perceptions of odor or flavor, for example, the perceptions of sweet versus sour. Odors can modify behavior, generate emotions, and evoke memories. Color can influence odor perception as shown, for example, by aroma determination tests of wine. See, e.g., Morrot, G. et al. (2001) Brain and Language. 79:309-320. Regarding odor itself, odor testing can result in experimental data taking the form of reports of pleasantness, unpleasantness, intensity, and duration of memory of a given odor. See, e.g., Richardson, J. et al. (1989) Psychological Bulletin. 105:352-360. A variety of tests are available for assessing the influence of color on the perceptions of a given liquid, for example, where color influences the perception of “refreshingness” or the perception of “thirst-quenchability.” See, e.g., Zellner, D. A. et al. (2003) Am. J. Psychol. 116:633-647. Color can be a more influential cue than taste in the consumers' perception of flavor and, in this way, a coloring can contribute to the marketing of a given product. See, e.g., Tom, G. et al. (1987) Consumer Marketing, 4:23-27.
- Food color influences perceived flavor intensity and identity. An example is oenophiles given white wine that has been colored red who described it with red wine flavor descriptors. A cause of decreased food intake that occurs with advancing age is loss of taste and smell acuity. The present disclosure provides compositions for use in flavor-amplified foods to improve nutritional status in elderly persons. Moreover, the present disclosure provides cannabis compositions, optionally with flavorings and colorings, to improve appetite.
- The present disclosure provides compositions and formulations where a coloring is included, and where the particular color influenced the subject towards certain odor-perceptions and also influenced the same subject away from other odor-perceptions.
- Briefly stated, the present disclosure provides a formulation comprising a coloring and an odorant, wherein the odorant provides a perceivable odor to the formulation, and wherein the coloring provides a perceivable color to the formulation. Also provided, is the above formulation, wherein in the coloring in pure form does not have a perceivable odor, and wherein the odorant in purified form does not have a perceivable color.
- In one embodiment described herein, a formulation is provided wherein the perceivable odor and/or flavor is representative of any fruit that is associated with a dominant color like the following fruit-color pairs: orange-orange, lemon-yellow, lime-green, or blueberry-blue. In one aspect of an embodiment described herein, the formulation comprises a coloring selected from the group consisting of violet, indigo, blue, green, yellow, orange, red, and a combination thereof. In another aspect of an embodiment described herein, the formulation is selected from the group consisting of a liquid, a slurry, a paste, an oil, a powdered solid, a non-powdered solid, and a combination thereof.
- In another embodiment described herein, the formulation comprises an odorant, wherein the odorant in purified form has a first odor, wherein the odorant in purified form mixed with a coloring in purified form has a second odor, and wherein the first odor is more intense than the second odor as determinable with perception tests with human subjects. In one aspect of an embodiment described herein, the formulation comprises an odorant, wherein the odorant in purified form has an odor, wherein the odorant in purified form mixed with a coloring in purified form has the same odor, but wherein, the odorant mixed with a coloring is more recognizable and/or more enjoyable as determined via perception tests with human subjects. In another aspect of an embodiment described herein, the formulation comprises an odorant, wherein the odorant in purified form has an odor that may be identified as smelling like a kind of fruit, wherein the odorant in purified form mixed with a coloring in purified form is more often identified as smelling like the fruit and is also perceived as more enjoyable to humans on average.
- In yet another embodiment described herein, the formulation comprises a flavorant, wherein the flavorant in purified form has a taste profile, wherein the flavorant in purified form mixed with a coloring in purified form has the same taste profile, but wherein, the flavorant mixed with a coloring is more recognizable and/or more enjoyable as determined via perception tests with human subjects. In one aspect of an embodiment described herein, the formulation comprises a flavorant, wherein the flavorant in purified form has an odor that may be identified as smelling like a kind of fruit, wherein the flavorant in purified form mixed with a coloring in purified form is more often identified as tasting like the fruit and is also perceived as more enjoyable to humans on average.
- In one embodiment described herein, the formulation can be used in an electronic cigarette. In one aspect of the embodiment described herein the electronic cigarette emits a smoke, wherein the coloring is perceived as having a color in the smoke emitted by the electronic cigarette or the coloring is not perceived at coloring the smoke at all.
- In another embodiment described herein, the formulation can be used in a beverage for human consumption. In yet another embodiment described herein, the formulation can be used in one or more of a skin lotion, perfume, and/or cosmetic. In yet another embodiment described herein, the formulation can be used in a confection, cake frosting, and/or candy. In one aspect of an embodiment described herein, the formulation comprises at least one plant pigment and at least one cannabinoid. In another aspect of an embodiment described herein, the formulation comprises at least one plant pigment and at least one terpene. In yet another aspect of an embodiment described herein, the formulation comprises at least one non-plant pigment and at least one cannabinoid. In yet another aspect of an embodiment described herein, the formulation comprises at least one non-plant pigment and at least one terpene.
- In one embodiment described herein, the formulation comprises D-Limonene, beta-caryophyllene, beta-myrcene, linalool, beta-pinene, alpha-humulene, alpha-bisabolol, alpha-pinene, and terpinolene; optionally with orange pigment (Tangie). In one aspect of the embodiment described herein, the formulation does not comprise any caryophyllene-oxide. In another aspect of the embodiment described herein, the formulation comprises an orange pigment, wherein the orange pigment acts by synesthesia to increase preference by a human subject of one or both of the odor or flavor of Tangie.
- In another embodiment described herein, the formulation comprises D-Limonene, beta-pinene, beta-caryophyllene, beta-myrcene, linalool, alpha-humulene, alpha-bisabolol, alpha-pinene, and terpinolene; optionally with yellow pigment (Lemon Kush). In one aspect of the embodiment described herein, the formulation does not comprise any caryophyllene-oxide. In another aspect of the embodiment described herein, the formulation comprises a yellow pigment, wherein the yellow pigment acts by synesthesia to increase preference by a human subject of one or both of the odor or flavor of Lemon Kush.
- In yet another embodiment described herein, the formulation comprises D-Limonene, beta-myrcene, alpha-pinene, beta-caryophyllene, beta-pinene, alpha-humulene, linalool, alpha-bisabolol, caryophyllene-oxide, and terpinolene; optionally with green pigment (Lime Dream). In one aspect of the embodiment described herein, the formulation comprises a green pigment, wherein the green pigment acts by synesthesia to increase preference by a human subject of one or both of the odor or flavor of Lime Dream.
- In yet another embodiment described herein, the formulation comprises beta-myrcene, beta-caryophyllene, D-Limonene, alpha-pinene, alpha-humulene, beta-pinene, linalool, alpha-bisabolol, terpinolene, caryophyllene-oxide, and terpinolene; optionally with blue pigment (Berry Cush). In one aspect of the embodiment described herein, the formulation comprises a blue pigment, wherein the blue pigment acts by synesthesia to increase preference by a human subject of one or both of the odor or flavor of Berry Cush.
- The foregoing four examples represent specific embodiments of odorant and flavorant formulations that are representative of the specific fruit moniker used in the odorant and flavorant name (e.g. Lime Dream). These examples are not intended to restrict the general principle of pairing a flavorant or odorant formulation that is representative of a fruit that is associated with a dominant color.
- The present disclosure provides a formulation for use in an electronic cigarette comprising a light emitting diode (LED) that produces a purple wavelength of light, wherein the formulation comprises about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids, and wherein the perception of grape odor is greater than that for the same formulation without LED or with the LED turned off.
- The present disclosure also provides a formulation for use in an electronic cigarette, wherein the formulation comprises 0.05%-5% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids, and wherein the perception of grape odor is greater than that for a formulation comprising 0-0.03% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids. The present disclosure also provides a formulation comprising about 10% terpenes, about 65% phytol, about 24.5% cannabinoids, and guaiazulene in an amount selected from the group consisting of 0%, 0.01%, 0.02%, 0.05%, 0.1%, 0.5%, 2.0%, 5.0%, and 10% guaiazulene.
- The present disclosure further provides a formulation for use in an electronic cigarette, wherein the formulation comprises 0.05%-5% of one or more azulene compounds, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids, and wherein the perception of grape odor is greater than that for a formulation comprising 0%-0.03% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids.
- Furthermore, the present disclosure provides a formulation for use in an electronic cigarette, wherein the formulation comprises 0.05%-5% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids, and wherein the perception of grape odor is greater than that for a formulation comprising 0%-0.03% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids.
- Furthermore, the present disclosure provides a formulation for use in an electronic cigarette, wherein the formulations comprising 0.05%-5% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids, and wherein the perception of grape flavor is greater than that for a formulation comprising 0%-0.03% guaiazulene, about 10% terpenes, about 65% phytol, and about 24.5% cannabinoids.
- Furthermore, the present disclosure provides a formulation for use in an electronic cigarette, wherein the formulation comprises 0.01%-0.05% chamazulene, about 5% terpenes, and about 94.99% cannabinoids, and wherein the perception of grape odor is greater than that for a formulation comprising 0%-0.005% chamazulene, about 5% terpenes, and about 94.99% cannabinoids.
- Furthermore, the present disclosure provides a formulation for use in an electronic cigarette, wherein the formulation comprises 0.01%- 0.05% chamazulene, about 5% terpenes, and about 94.99% cannabinoids, and wherein the perception of grape flavor is greater than that for a formulation comprising 0-0.005% chamazulene, about 5% terpenes, and about 94.99% cannabinoids.
- As used herein, including the appended claims, the singular forms of words such as “a,” “an,” and “the” include their corresponding plural references unless the context clearly dictates otherwise. Al references cited herein are incorporated by reference to the same extent as if each individual publication, patent, and published patent application, as well as figures and drawings in said publications and patent, documents, was specifically and individually indicated to be incorporated by reference.
- Expressly incorporated by reference herein in their entirety are all serial numbers, patents, granted and issued overseas: Ser. No. 14/467,565 filed Aug. 25, 2014; PCT/US2014/056249 filed Sep. 18, 2014; U.S. Letters U.S. Pat. No. 9,732,009, issued Aug. 15, 2017; PCT2014/064860 filed Nov. 10, 2014; Ser. No. 15/014,716 filed Feb. 3, 2016; Ser. No. 15/097,197 filed Apr. 12, 2016; PCT/US16/44929 filed Jul. 30, 2016; Ser. No. 15/250,475 filed Aug. 29, 2016; 62/518,703 filed Jun. 13, 2017; Ser. No. 15/676,744 filed Aug. 14, 2017; 62/553,817 filed Sep. 2, 2017; 62/556,418 filed Sep. 9, 2017; Ser. No. 15/826,203 filed Nov. 29, 2017; PCT/US15/55272 filed Oct. 13, 2015; Ser. No. 14/882,018 filed Oct. 13, 2015; AU 2014 323 509 filed Sep. 18, 2014; CA 2,923,091 filed Sep. 18, 2014; IL Patent No. 244399, granted May 29, 2017; IN 201617007409 filed Sep. 18, 2014; RU 2016107794 filed Sep. 18, 2014; ES P201690015 filed Sep. 18, 2014; IL Patent No. 245469 granted May 29, 2017; IN 201617015721 filed Nov. 10, 2014; RU 2016117582 filed Nov. 10, 2014; ES Patent No. 2576464 issued May 19, 2017; AU 2015 333 703 filed Oct. 13, 2015; IL 251660 filed Oct. 13, 2015; IN 201717013784 filed Oct. 13, 2015; JP 2017-519651 filed Oct. 13, 2015; RU 2017112763 filed Oct. 13, 2015; ES 201790019 filed Oct. 13, 2015; UK 1707675.3 filed Oct. 13, 2015; CZ PV2017-259 filed Oct. 13, 2015; CA 2,994,266 filed Jul. 30, 2016; IL 257268 filed Jul. 30, 2016; Ser. No. 15/749,358 filed Jan. 31, 2018; AU 2018 201 704 filed Mar. 9, 2018.
- The term “coloring” as used herein refers to a physical entity such as a chemical, molecule, metal ion, complex of metal ion. light-producing element, like a light-emitting diode (LED), and a molecule, composition comprising one or more of the above, composition consisting of one or more of the above, and the like, where the “coloring” is perceivable as having a color. Without implying any limitation, in some embodiments, a “coloring” in a relatively pure form or in a pure form, is perceivable as having a color, while in other embodiment, the “coloring” is perceivable as having a color only when subject to a specific environmental condition, such as an acid pH or a neutral pH. The color can be selected from the group consisting of violet, indigo, blue, green, yellow, orange, red, and a combination thereof.
- The term “odorant” as used herein refers to a chemical compound or a mixture of chemical compounds with a smell detectable by a human nose. The term “flavorant” as used herein refers to a flavor additive or multiple flavor additives that modify the flavor of a composition compared to if the flavorant was not present. The term “pigment” as used herein refers to a composition or compositions that can be identified or distinguished by names of chemicals and where the pigment is perceivable as having a color. The term “colorant” as used herein refers to a substance or a mixture of substances that is added to change the color of a composition.
- In one embodiment described herein, the formulation may comprise one or more terpenes selected from the group consisting of alpha-bisabolol, borneol, camphene, camphor, beta-caryophyllene, delta-3-carene, caryophyllene oxide, alpha-cedrene, beta-eudesmol, fencholfenchyl alcohol, geraniol, guaiol, alpha-humulene, isoborneol, limonene, linalool, menthol, myrcene, nerol, nerolidol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, sabinene, 4-thujanol, alpha-terpinene, alpha-terpineol, terpinolene, alpha-guaiene, elemene, farnesene, farnesol, germacrene B, guaia-1(10),11-diene, trans-2-pinanol, selina-3,7(11)-diene, eudesm-7(11)-en-4-ol, valencene, and a mixture thereof.
- In one embodiment described herein, the formulation may comprise one or more cannabinoids selected from the group consisting of tetrahydrocannabinol, delta-9-tetrahydrocannabinol (THC), delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol propyl analogue (THCV), cannabidiol (CBD), cannabidiol propyl analogs (CBDV), cannabinol (CBN), cannabichromene (CBC), cannabichromene propyl analogs (CBCV), cannabigerol (CBG), their corresponding cannabinoid acid counterparts, and a mixture thereof.
- In one embodiment, a formulation described herein may comprise carriers or diluting oils such as dipropylene glycol, coconut oil, and glucam P-20, propylene glycol, triacetin, vegetable glycerin are available from, e.g., Perfumers Apprentice (Scotts Valley, Calif.). Colorings and pigments are available from, e.g., American Colors, Inc., Sandusky, Ohio. Natural aroma chemicals, synthetic aroma chemicals, and essential oils and extracts are available from, for example, Vigon International, East Stroudsburg, Pa.. Violet-colored azulene compounds are disclosed by, e.g., Hayashi (1968) Bulletin of the Chemical Society of Japan. 41:2182-2183.
- Standard color charts are available, for example, from Long, J. (2011) The New Munsell Student Color Set, 3rd ed. Fairchild Books; Centore, P. (2015) Controlling Colour With the Munsell System. ISBN-10:1632270129. The Munsell System is used in psychology experiments. See, e.g., Gilbert, A. N. et al. (1006) Cross-modal correspondence between vision and olfaction: the color of smells. Am. J. Psychology. 109:335-351.
- Other standard color charts include: ROL Colors. The RAL system is a Central European Color Standard, and RAL color charts are available from Color Harzen. General chemical reagents, as well as colorings, solvents, and surfactants are available (Sigma Aldrich, St. Louis, Mo.; Fischer Chemicals, Fair Lawn, N.J.; Ceriliiant, Round Rock, Tex.; Promochem, Molsheim, France, Cayman Chemical Co., Ann Arbor, Mich.). Useful labels include 33P, 35S, 14C, 3H, stable isotopes, fluorescent dyes, or fluorettes. See, e.g., Rozinov and Nolan (1998) Chem. Biol. 5:713-728. Terpenes, cannabinoids, formulations, and methods for preparation and analysis are available from US2015/0080265 of Elzinga and Raber, US2015/0152018 of Raber and Elzinga, 2017/0021029 of Raber et al, and 2016/0151328 of Doane and Raber, the disclosures of each of which are incorporated herein in their entirety.
- The present disclosure provides compositions, reagents, and combinations of reagents, that act by way of synesthesia. Synesthesia encompasses, but is not limited to, a phenomenon where a stimulus in one sensory mode is interpreted in terms of some other sensory mode. For example, colors can bias odor judgments. Odor judgments include, and are not limited to, accuracy in odor identification. A synesthesia questionnaire can take the form of a paper that invokes a mood, such as angry, tired, proud, peaceful, surprised, excited, joyful, and so on, and where the subjected reports the evoked mood (e.g., yellow perceived as joyful, red as surprised, blue as peaceful). Also, the subject can be presented with an odor sample, and be asked to report the evoked color. Fragrances of the present disclosure can be dissolved in diethyl phthalate, where odor chemicals are present in an amount ranging from 0.1% to 80% of the amount of the composition. In one embodiment, the odor chemical are present in an amount ranging from 0.1% to 1%, 0.5% to 2.0%, 1.0% to 5.0%, 2.5% to 7.5%, 5% to 10%, 7.5% to 15%, 10% to 20%, 15% to 25%, 20% to 30%, 25% to 35%, 30% to 40%, 35% to 45%, 40% to 50%, 45% to 55%, 50% to 60%, 55% to 65%, 60% to 70%, 65% to 75%, or 70% to 80% of the amount of the composition. Alternatively, the odor chemical can be used at 100% strength. See, Gilbert, A. N. et al. (1996) Am. J. Psychology. 109:335-351; and Rader and Tellegen (1987) J. Personality and Social Psychology. 52:981-987.
- The present disclosure provides compositions, formulations, solutions, and the like, can be used with an electronic cigarette (e-cigarette). Apparatus and formulations for e-cigarettes are available. See, U .S. Pat. No. 9,254,002 of Chong and U.S. Pat. No. 8,997,753 of Li, which are incorporated herein in their entirety. In embodiments, the compositions, formulations, and solutions of the present disclosure can be converted to an aerosol, and in other embodiments, take the form of an aerosol.
- The reagents and compositions of the present disclosure can be used in combination with, or can be contained within, one or more of the devices described herein. The devices include a moist towel in a tearable aluminum foil envelope; scented soft paper tissue, e.g., Kleenex®.; a cartridge that goes inside a bong, or water pipe, or hookah, where the composition supplements the flavor or medicinal effects of the marijuana smoke; an inhaler for people with asthma, where the composition is mixed with and supplements the anti-inflammatory drugs present in the inhaler; coaled porous particles and/or coated non-porous particles, wherein the particles have terpenes and cannabinoids soaked into the particles; mixed in a hangover treatment (not necessary medicinal); as part of a composition with capsaicin (chili pepper chemical) for use in treating pain, for topical application, for arthritis pain or as part of an existing arthritis pain topical cream; lip balm; and/or as a component of an oil-based cosmetic for skin.
- DABS. Dabs are a means for consuming cannabis concentrates via vaporization and inhalation. A dab usually refers to a dose of concentrate that is heated on a hot surface, usually a nail, and then inhaled through a dab rig. Dabs are concentrated doses of cannabis that are made by extracting THC and other cannabinoids using a solvent such as butane or carbon dioxide, resulting in sticky oils commonly referred to as wax, shatter, budder, and/or butane hash oil (BHO). While it is possible to extract non-psychoactive compounds like CBD, THC is what is behind the potent effects of dabs, increasing efficiency in administration of medications. Terpenes or the aromatic oils that give cannabis flavor, can also be extracted. The present disclosure provides methods of use, methods of manufacture, and compositions and reagents for use with administration by way of dabs.
- ECIG COMPONENTS. The present disclosure provides devices and methods for storing the compositions described herein inside of a vapor cartridge (ecig component) or other device or object. Devices and objects may be color coded to indicate flavor suggestions, and optionally also to indicate if it contains THC or CBD (or other cannabinoid). A non-limiting physical structure of the ecig includes: (1) chip/microcontroller for voltage regulation, run lights or vibration, flow cell monitoring; (2) LEDs/vibrating motor for visual and tactile feedback; (3) battery or other energy source to supply power; (4) a chamber to hold material to be vaporized, wherein the chamber can be of many shapes and materials; (5) mouthpiece; (6) heating element to vaporize the material, wherein the heating element can be made in many shapes and material; (7) 510 thread as a standardized linkage between cartridges of material and the battery/electronics. The chamber part (also known as a cartridge) is where the composition is held. Compositions could be placed in vapor cartridges that are transparent in their construction to allow seeing the composition. In a vapor cartridge it is intended to be smelled by the nose during exhale and tasted by the tongue on inhalation. In other uses, such as a dab, the user may intend to smell before inhalation or smell during exhalation, or both. The mode of delivery drives whether an aroma can be appreciated during the inhale, during the exhale, or both. The present disclosure provides methods of use, methods of manufacture, and compositions and reagents for use with administration by way of an ecig.
- Methods for conducting odorant perception tests are also described herein. In one type of test subjects are instructed to describe the odor of various fruit solutions, some of which are inappropriately colored. Then, subjects are presented with a series of fruit solutions which vary in odor and color intensity and then asked to rank them in order of odor strength. See, Blackwell L (1995) Nutrition and Food Science. 95:24-28. In another type of test, an odorant is presented in one of 16 different dilutions. The odorant may or may not be colored. Also, a picture or photograph of a possible source of the odorant may or may not be shown to the subject, for example, a picture of a ham, cookie, or melon. The subject then identifies the odorant. See, Gudziol, V. and Hummel, T. (2009) Arch. Otoloaryngol. Head Neck Surg. 135:1431-1435. In other types of tests, stimulant delivery occurred via squeezable polyethylene bottles that could deliver odorized air directly into the nostril, or alternatively, into air located below the nostrils. See, Rabin, M. D. and Cain, W. S. (1986) Perception Psychophysics. 39:281-286.
- Entourage compounds and entourage effects are encompassed by the present disclosure. The methods, compositions, reagents, and devices of the present disclosure encompass entourage effects of cannabis and cannabinoids, including entourage effects provided by terpenes. Interactions between phytocannabinoids and terpenoid compounds can act synergistically for treating pain, inflammation, depression, anxiety, and addiction. Ben-Shabat, et al. provide an example of an entourage effect. 2-Arachidonoyl-glycerol is an endogenous ligand for both cannabinoid receptors, CB1 and CB2. The biological activity of 2-arachidonoyl-glycerol can be increased by related 2-acyl-glycerols, which alone show little or no activity. This effect (entourage effect) enhances activity of cannabinoids. 2-linoleoyl-glycerol and 2-palmitoyl-glycerol are two esters that neither bind to cannabinoid receptors nor inhibit adenylyl cyclase via either CB1 or CB2, but they can potentiate the binding of 2-arachidonoyl-glycerol. See, Ben-Shabat, et al. (1998) Eur. J. Pharmacol. 353:23-31. Huestis provides another example of entourage effect and entourage compounds. Ethanolamines such as palmitoylethanolamine or stearoylethanolamine do not bind to CB1 or CB2 cannabinoid receptors, but they potentiate activity of ligands of cannabinoid receptors. See, Huestis (2002) Forensic Sci. Rev. 14:15-60.
- The method of conducting odor and flavor testing described herein, in general terms, involves asking subjects to identify a specific odor or flavor presented to them and then to tally the number of correct answers versus incorrect answers. In addition, the human subjects can be asked to rate the enjoyment of the flavor and or aroma of a product. To test for a synesthetic response, both of these tests can be done while exposing the subject to light from an LED that is emitting either a matched color (i.e. the dominant color associated with a fruit, e.g. lime with green) or a mismatched color (e.g. lime with red). In comparing the paired responses, one is able to discriminate the impact of the LED on both representative flavor/odor identification and overall enjoyment.
- A method of conducting odor and flavor testing described herein, in specific terms, involves presenting a human subject with an unmarked e-cigarette containing a formulation consisting, by weight percentage, of 10% flavor/odorant formulation, 10% cannabidiol, and 80% phytol; wherein the composition of the flavorant/odorant blend varies as demonstrated in the examples that follow. As soon as the administrator of the experiment presents a cartridge to the subject, an LED light (ELlight brand 300 color LED controlled with the LED Hue iPhone app) is switched on to a specific color and maintained on that color until the subject verbally records flavor/aroma identification assessments and an overall enjoyment rating from 1-10 with 1 being the least enjoyment and 10 meaning the most enjoyment possible. Each subject is presented the same flavor twice—once with a matched color and once with a mismatched color. This allows for the measurement of the impact that the color from the LED has on the flavor identity assessments and overall enjoyment, in a relative way.
- Table 1 illustrates mapping of dominant colors (i.e. matched colors) used in the experimental protocol described in the preceding paragraphs to the wavelength ranges of light emitted by LED.
-
TABLE 1 Colors, Wavelength Ranges & Associated Fruits Color Wavelength Range (nm) Example Fruits Red 620-750 Strawberry, Cherry, Red Apple Orange 590-620 Orange, Mango, Peach Yellow 570-590 Lemon, Banana, Pineapple Green 495-570 Lime, Kiwi, Pear, Honeydew Blue 450-495 Blueberry, Plum, Grape Violet 380-450 Grape, Blackberry, Acai - Strawberry cough is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (27%) , beta-pinene (5%), beta-caryophyllene (17%), beta-myrcene (17%), linalool (6%), alpha-humulene (3%), alpha-bisabolol (2%), alpha-pinene (2%), terpinolene (<1%), and caryophyllene-oxide (<1%). This formula also comprises a compound found in strawberries, but not found in cannabis. As such, the taste and odor of the composition is both of strawberries and of the cannabis strain strawberry cough. When matched with a red light 4 out of 5 subjects correctly identified the taste/odor as having a strawberry representative flavor with an overall enjoyment rating of 6.4 out of 10. When mismatched with a yellow light only 1 out of 5 subjects reported strawberry aroma or flavor with an average enjoyment rating of 5.8.
- Tangie is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (22%), beta-pinene (4%), beta-caryophyllene (17%), beta-myrcene (17%), linalool (7%), alpha-humulene (4%), alpha-bisabolol (2%), alpha-pinene (2%), terpinolene (<1%), and caryophyllene-oxide (<1%). This formula also comprises multiple compounds found in tangerines and other citrus fruit, but not found in cannabis. As such, the taste and odor of the composition is both of tangerines/citrus and of the cannabis strain Tangie. When matched with an orange light 5 out of 5 subjects correctly identified the taste/odor as having a tangerine or citrus representative flavor with an overall enjoyment rating of 7.6 out of 10. When mismatched with a purple light only 2 out of 5 subjects reported a tangerine or citrus aroma or flavor with an average enjoyment rating of 4.8.
- Lemon Kush is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (49%) , beta-pinene (9%), beta-caryophyllene (9%), beta-myrcene (9%), linalool (3%), alpha-humulene (2%), alpha-bisabolol (1%), alpha-pinene (1%), terpinolene (<1%), and caryophyllene-oxide (<1%). This formula also comprises multiple compounds found in lemons, but not found in cannabis. As such, the taste and odor of the composition is both of lemons and of the cannabis strain Lemon Kush. When matched with a yellow light 4 out of 5 subjects correctly identified the taste/odor as having a lemon or citrus representative flavor with an overall enjoyment rating of 4.8 out of 10. When mismatched with a purple light only 1 out of 5 subjects reported a citrus aroma or flavor with an average enjoyment rating of 5.0.
- Kiwi Kush is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (12%) , beta-pinene (2%), beta-caryophyllene (19%), beta-myrcene (7%), linalool (3%), alpha-humulene (<1%), alpha-bisabolol (3%), alpha-pinene (1%), terpinolene (<1%), and caryophyllene-oxide (<1%). This formula also comprises multiple compounds found in kiwis, but not found in cannabis. As such, the taste and odor of the composition is both of kiwis and of cannabis. When matched with a green light 3 out of 5 subjects correctly identified the taste/odor as having a kiwi representative flavor with an overall enjoyment rating of 7.4 out of 10. When mismatched with a blue light only 2 out of 5 subjects reported a kiwi aroma or flavor with an average enjoyment rating of 6.6.
- Blueberry Flame is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (25%) , beta-pinene (5%), beta-caryophyllene (16%), beta-myrcene (24%), linalool (5%), alpha-humulene (3%), alpha-bisabolol (1%), alpha-pinene (2%), terpinolene (<1%), and caryophyllene-oxide (<1%). This formula also comprises one compound found in blueberries, but not found in cannabis. As such, the taste and odor of the composition is both of blueberries and of cannabis. When matched with a blue light 1 out of 5 subjects correctly identified the taste/odor as having a blueberry representative flavor with an overall enjoyment rating of 4.2 out of 10. When mismatched with a red light 0 out of 5 subjects reported a blueberry aroma or flavor with an average enjoyment rating of 4.8.
- Grapeness is a flavor composition comprising the following compounds and weight percentages in parentheses: limonene (18%), beta-pinene (4%), beta-caryophyllene (13%), beta-myrcene (13%), linalool (5%), alpha-humulene (3%), alpha-bisabolol (2%), alpha-pinene (2%), terpinolene (<1%), and caryophyllene-oxide (<1%). This formula also comprises multiple compounds found in grapes, but not found in cannabis. As such, the taste and odor of the composition is both of grapes and of cannabis. When matched with a purple light 5 out of 5 subjects correctly identified the taste/odor as having a grape representative flavor with an overall enjoyment rating of 7.2 out of 10. When mismatched with an orange light 4 out of 5 subjects reported a grape aroma or flavor with an average enjoyment rating of 5.4.
- In aggregate, the matched fruit flavors/aromas and dominant color light pairings highlighted in examples 1-6 resulted in an average of two more correct representative flavor assessments than incorrect. In contrast, the mismatched flavors resulted in an average of two more incorrect flavor assessments than correct. In addition, the matched fruit flavors/aromas and dominant color light pairings resulted in an average enjoyment score of 6 out of 10 across all flavors while the mismatched fruit flavors/aromas and dominant color light pairings resulted in an average enjoyment score of 5 out of 10.
- The results of the raw data from the experiment that led to the data described in the six preceding examples is presented in Table 2.
-
TABLE 2 Cartridge & LED Color Pairing Cartridge LED Avg. Code Color Subject 1 Subject 2 Subject 3 Subject 4 Subject 5 Subjects A Yellow Flavor Guess Melony, Same Melon Berry, Lemon Lemony Enjoyment Rating 7 5 8 5.8 B Purple Flavor Guess Grape, Grapey ? Grape, Grapey 0 Enjoyment Rating 7 7 3 3 4.8 C Green Flavor Guess Taste Green, Citrusy & Piney Kiwi Kush ? Green fruit −3 Enjoyment Rating 7 7 6 2 3 5.0 D Red Flavor Guess None, Blank None No flavor Strawberry No flavor 3 Enjoyment Rating 1 0 2 6 1 2.0 E Blue Flavor Guess Berry Flavor or Kiwi Blueberry Berry Kiwi −1 Enjoyment Rating 6 8 7 8 4 6.6 F Red Flavor Guess Does not taste much Strawberry, Sweet, Strawberry Cough ? Strawberry Enjoyment Rating 3 7 6 2 G Orange Flavor Guess Citrusy & orange Grapey but bitter & Grapeness Grape Grape 3 Enjoyment Rating 7 4 4 5.4 A Red Flavor Guess Strawberry Taste, Sweet & Berry, Lemon Kush Strawberry Strawberry 3 Enjoyment Rating 7 7 6 6.4 B Orange Flavor Guess Orange, sweet, Sweet, Citrusy, Tangerine Tangerine 5 Enjoyment Rating 8 7 9 8 7.6 C Yellow Flavor Guess Lemony Terpentine, citrusy, Lemon Kush Bad Lemon 3 Enjoyment Rating 6 5 6 1 6 4.8 D No Color Flavor Guess Flavorless, No Flavor No Flavor No Flavor Nothing No Flavor 5 Enjoyment Rating 1 0 1 2 1 1.0 E Green Flavor Guess Guava Sweet & Fruity, Strawberry Cough Kiwi Kiwi 1 Enjoyment Rating 8 8 5 8 8 7.4 F Blue Flavor Guess Doesn't Taste much, Berry, Piney, Lemon Kush Pine-ish Juniper Berry Enjoyment Rating 2 6 4.2 G Purple Flavor Guess Grape & Berry Berry, bitter, Grapeness Grape Grape, Grapey 5 Enjoyment Rating 8 6 7 8 7 7.2 indicates data missing or illegible when filed - Generally, the term pigment refers to compositions that can be identified or distinguished by names of chemicals and where the pigment is perceivable as having a color. The term color refers to what is perceived by a human subject. The color can also be determined by a spectrophotometer.
- Potential Pigments can be selected from the group consisting of Guaiene sesquiterpenes, carotenoids, anthocyanins, anthocyanidins, and diarylheptanoids. Guaiane sesquiterpenes—guaiazulene and vetriazulene, xanthophylls (bixins E160b, apocarotenal E160e, food orange 7 E160f, flavoxanthin E161 a, lutein E161 b cryptoxanthin E161c, rubixanthin E161d. violaxanthin E161e, rhodoxanthin E161f, canthaxanthin E161g, zeaxanthin E161f, citranaxanthin E161i, astaxanthin E161j). carotenes (lycopene E160d, beta-carotene E160a) diarylheptanoids (curcumin E100, curcumenoids), Antbocyanidins and anthocyanins, betanin (E162), carmine, chlorophyllin (E141) natural green 3.
- Native Pigments can be selected from the group consisting of neoxanthin, violaxenthin, zeaxanthin, lutein, b-cryptoxanthin, b-carotene, chlorophyll a & b, and guaizulene.
- Colors of Pigments: Guaiazulene can be used to color a clear extract shades of blue or yellow extract shades of yellow-green. Carotene and lutein can be used to color extracts orange. Lycopene can be used to color extracts orange-red. Curcumins can be used to color an extract bright yellow and make them fluoresce under UV radiation. Guaiazulene and curcumins together can make shades of green that fluoresce. Anthocyanins can make extracts many shades of purple, red and blue.
- Smell of Pigments: The present disclosure demonstrates that the pigmentation of cannabis extracts does not lead to off flavors.
- OFF-FLAVOR TESTING. Methods and equipment for detecting and quantifying off-flavors are available. See, for example. Marsili, R. G. (1999) SPME-MS-MVA as an Electronic Nose for the Study of Off-Flavors in Milk. J. Agric. Food Chem., 47:648-654; Wilkes, J. G. et al. (2000) Sample preparation for the analysis of flavors and off-flavors in foods. Journal of Chromatography A. 880:3-33; and Benanou, D. et al. (2003) Analysis of off-flavors in the aquatic environment by stir bar sorptive extraction—thermal desorption—capillary GC/MS/olfactometry. Analytical Bioanalytical Chem. 376:69-77.
- Solubilities of Pigments: Anthocyanins are only soluble in dipropylene glycol (i.e. OBP), not in nexus or cannabinoids alone. Anthocyanins in OBP can be added to cannabinoids and terpenes to make red colored extracts. Guaiazulene is soluble in cannabinoids, terpenes, nexus, and obp and all useful combinations. Curcumins are soluble at necessary levels for full pigmentation of obp, nexus, and terpenes. Lutein and carotene are soluble in obp, nexus, terpenes, and cannabinoids.
- Non-Chemical Pigment Influences: Pigments may be modified by use of light, lightwaves, ultrasonic waves, other sound wave, and wave influences. LED lights on apparatuses that may contain the pigments or be in touch with the pigments, being soluble in obp, nexus, terpenes or cannabinoids.
- Preference Testing by Human Subjects
- The present disclosure provides, without implying any limitation, protocol for testing preferences by human subjects. The protocol can require that human subject designate either preferred or not preferred. Another embodiment for protocol can require that the subject designate preference in terms of a scale, for example, a scale ranging from zero (least preferred) to ten (most preferred), where the scale takes the form of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Also, the scale can range from zero to two (0, 1, 2), or zero to three (0, 1, 2, 3), or zero to four (0, 1, 2, 3, 4), and the like. The process and composition of the present disclosure can exclude any composition, or can exclude any method that uses a composition, where the composition was not determined to be preferred by at least 50% of a population of human subjects (where preference was determined under controlled laboratory testing conditions).
- In a preferred embodiment of the present composition and related methods, the composition can require preference by human subjects in a controlled laboratory testing environment, that a given composition be preferred (in tests given only the option of preferred versus not preferred), by at least 20%, by at least 30%, by at least 40%, by at least 50%, by at least 60%, by at least 70%, by at least 80%, by at least 90%, or by at least 95% of the human subjects.
- In yet another preferred embodiment of the present composition and related methods, the composition can require preference by human subjects in a controlled laboratory testing environment, that a given composition be preferred (in tests giving the options of zero (least preferred), one, and two (most preferred)), that a preference value of “two” is designated by at least 20%, by at least 30%, by at least 40%, by at least 50%, by at least 60%, by at least 70%, by at least 80%, by at least 90%, or by at least 95% of the human subjects.
- In yet another preferred embodiment of the present composition and related methods, the composition can require preference by human subjects in a controlled laboratory testing environment, that a given composition be preferred (in tests giving the options of zero (least preferred), one, two, and three (most preferred)), that a preference value of “two” is designated by at least 20%, by at least 30%, by at least 40%, by at least 50%, by at least 60%, by at least 70%, by at least 80%, by at least 90%, or by at least 95% of the human subjects.
- In yet another preferred embodiment of the present composition and related methods, the composition can require preference by human subjects in a controlled laboratory testing environment, that a given composition be preferred (in tests giving the options of zero (least preferred), one, two, and three (most preferred)), that a preference value of “three” is designated by at least 20%, at least 30%, by at least 40%, by at least 50%, by at least 60%, by at least 70%, by at least 80%, by at least 90%, or by at least 95% of the human subjects. This criterion optionally can be combined with the criterion set forth in the previous paragraph.
- What can be excluded is any composition or method, where the composition was not determined to be preferred by at least 60%, by at least 70%, by at least 80%, by at least 85%, by at least 90%, by at least 95%, by at least 99% of the human subjects. For these exclusionary embodiments, the term “preferred” can refer to tests that required either a yes/no preference level.
- Alternatively, where tests require that subjects designate a preference on a scale of zero to three, or zero to four, or zero to five, and so on, what can be excluded are compositions and method, where at least 50% of the subjects did not designate at least a “two,” or where at least 50% of the subjects did not designate at least a “three,” or where at least 50% of the subjects did not designate at least a “four,” or where at least 50% of the subjects did not designate at least a “five,” or where at least 50% of the subjects did not designate at least a “six” or where at least 50% of the subjects did not designate at least a “seven,” or where at least 50% of the subjects did not designate at least an “eight,” and so on.
- Certain embodiments described herein include the best mode known to the inventors for carrying out the process and/or creating a composition. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. A skilled artisan may employ such variations as appropriate, and the methods described herein cab be practiced otherwise than specifically described herein. Accordingly, the present disclosure includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the present disclosure unless otherwise indicated herein or otherwise clearly contradicted by context.
- While the present disclosure has been described in terms of its specific embodiments, certain modifications and equivalents will be apparent to those skilled in the art and are intended to be included herein.
Claims (24)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/241,046 US20210244078A1 (en) | 2017-06-13 | 2021-04-26 | Unexpectedly enhanced pigments compositions and processes |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762518703P | 2017-06-13 | 2017-06-13 | |
US16/007,936 US20180360100A1 (en) | 2017-06-13 | 2018-06-13 | Unexpectedly Enhanced Pigments Compositions and Processes |
US17/241,046 US20210244078A1 (en) | 2017-06-13 | 2021-04-26 | Unexpectedly enhanced pigments compositions and processes |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/007,936 Continuation-In-Part US20180360100A1 (en) | 2017-06-13 | 2018-06-13 | Unexpectedly Enhanced Pigments Compositions and Processes |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210244078A1 true US20210244078A1 (en) | 2021-08-12 |
Family
ID=77178850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/241,046 Pending US20210244078A1 (en) | 2017-06-13 | 2021-04-26 | Unexpectedly enhanced pigments compositions and processes |
Country Status (1)
Country | Link |
---|---|
US (1) | US20210244078A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023247962A1 (en) * | 2022-06-24 | 2023-12-28 | Nicoventures Trading Limited | Aerosolisable formulation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8915254B2 (en) * | 2005-07-19 | 2014-12-23 | Ploom, Inc. | Method and system for vaporization of a substance |
US20160346339A1 (en) * | 2015-01-31 | 2016-12-01 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
-
2021
- 2021-04-26 US US17/241,046 patent/US20210244078A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8915254B2 (en) * | 2005-07-19 | 2014-12-23 | Ploom, Inc. | Method and system for vaporization of a substance |
US20160346339A1 (en) * | 2015-01-31 | 2016-12-01 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
Non-Patent Citations (2)
Title |
---|
Ferrinne Spector and Daphne Maurer. "Making Sense of Scents: The Colour and Texture of Odours," Seeing and Perceiving 25 (2012) 655–677 (Year: 2012) * |
Lemon_Oil_-_an_overview___ScienceDirect_Topics.pdf (Year: 2023) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023247962A1 (en) * | 2022-06-24 | 2023-12-28 | Nicoventures Trading Limited | Aerosolisable formulation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11857530B2 (en) | Cannabinoid formulations | |
US20210220323A1 (en) | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene or mineral | |
US20240110124A1 (en) | Terpene-based compositions, methodolgies for creation and products thereby | |
US10821147B2 (en) | Printable cannabinoid and terpene compositions | |
US20210352956A1 (en) | Cannabis based moist snuff | |
CA3054690A1 (en) | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes | |
Genovese et al. | Influence of olive oil phenolic compounds on headspace aroma release by interaction with whey proteins | |
US20170367386A1 (en) | Terpene flavoring compositions | |
US20210038666A1 (en) | Printable cannabinoid and terpene compositions | |
US20200297025A1 (en) | Method of manufacturing vape oil including a cannabinoid for use in a vape device | |
US20210204591A1 (en) | Terpenes and thc compositions and methods | |
US20210244078A1 (en) | Unexpectedly enhanced pigments compositions and processes | |
US20220125755A1 (en) | Cannabis time release apparatus and method of manufacture thereof | |
US20180360100A1 (en) | Unexpectedly Enhanced Pigments Compositions and Processes | |
US20220211660A1 (en) | High viscosity thc product and method of manufacture thereof | |
EP3261629A1 (en) | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral | |
US20200172841A1 (en) | Alcohol-free wine beverage | |
US20220125810A1 (en) | Thc container apparatus and method of use thereof | |
WO2021151212A1 (en) | System and method for quantifying, formulating and enhancing user experience profile of cannabis | |
Brown et al. | Budtender Medical Cannabis Certification Program | |
WO2019171170A1 (en) | Device and method for administering an active ingredient | |
Siddiqui et al. | Consumers left at the mercy of chefs for potency, consistency, safety and regulation—the edibles industry of cannabinoids—A critical review | |
US20220127041A1 (en) | Thc beverage container apparatus and method of use thereof | |
US20220125756A1 (en) | Thc-alcohol apparatus and method of manufacture thereof | |
Rhind | Listening to scent: an olfactory journey with aromatic plants and their extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION UNDERGOING PREEXAM PROCESSING |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- INCOMPLETE APPLICATION (PRE-EXAMINATION) |
|
AS | Assignment |
Owner name: SCIENTIFIC HOLDINGS, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RABER, JEFFREY CHARLES;DOUGLASS, BRADLEY J;REEL/FRAME:061551/0814 Effective date: 20210506 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |